“If we are to continue to solve the toughest health challenges of tomorrow, we need to cultivate the talent today. I can say with authority that employers will be waiting, but more importantly, patients are waiting. At MedImmune we are driven to create life-saving medicines — a process that does not happen without people who fundamentally love science and live to innovate; programs like ATLAS are critical to nurturing that passion early on so that it can thrive.”— Dr. JoAnn Suzich, Vice President of Research, MedImmune